Literature DB >> 33608830

Association of lncRNA with regulatory molecular factors in brain and their role in the pathophysiology of schizophrenia.

Parinita Mishra1, Santosh Kumar2.   

Abstract

Schizophrenia is one of the most agonizing neurodegenerative diseases of the brain. Research undertaken to understand the molecular mechanism of this disease has undergone a transition and currently more emphasis is put on long noncoding RNA (lncRNA). High expression level of lncRNA in the brain contributes to several molecular pathways essential for the proper functioning of neurons, neurotransmitters, and synapses, that are often found dysfunctional in Schizophrenia. Recently, the association of lncRNA with various molecular factors in the brain has been explored to a considerably large extent. This review comprehends the significance of lncRNA in causing profound regulatory effect in the brain and how any alterations to the association of lncRNA with regulatory proteins, enzymes and other noncoding RNA could contribute to the aetiology of Schizophrenia.

Entities:  

Keywords:  Neurons; Proteins; Schizophrenia; Synapse; lncRNA; miRNA

Mesh:

Substances:

Year:  2021        PMID: 33608830     DOI: 10.1007/s11011-021-00692-w

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  63 in total

1.  Transcriptome sequencing during mouse brain development identifies long non-coding RNAs functionally involved in neurogenic commitment.

Authors:  Julieta Aprea; Silvia Prenninger; Martina Dori; Tanay Ghosh; Laura Sebastian Monasor; Elke Wessendorf; Sara Zocher; Simone Massalini; Dimitra Alexopoulou; Mathias Lesche; Andreas Dahl; Matthias Groszer; Michael Hiller; Federico Calegari
Journal:  EMBO J       Date:  2013-11-15       Impact factor: 11.598

2.  The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing.

Authors:  G Barry; J A Briggs; D P Vanichkina; E M Poth; N J Beveridge; V S Ratnu; S P Nayler; K Nones; J Hu; T W Bredy; S Nakagawa; F Rigo; R J Taft; M J Cairns; S Blackshaw; E J Wolvetang; J S Mattick
Journal:  Mol Psychiatry       Date:  2013-04-30       Impact factor: 15.992

3.  GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss.

Authors:  A M Addington; M Gornick; J Duckworth; A Sporn; N Gogtay; A Bobb; D Greenstein; M Lenane; P Gochman; N Baker; R Balkissoon; R K Vakkalanka; D R Weinberger; J L Rapoport; R E Straub
Journal:  Mol Psychiatry       Date:  2005-06       Impact factor: 15.992

4.  LncRNA TUG1 sponges microRNA-9 to promote neurons apoptosis by up-regulated Bcl2l11 under ischemia.

Authors:  Shengcai Chen; Mengdie Wang; Hang Yang; Ling Mao; Quanwei He; Huijuan Jin; Zi-Ming Ye; Xue-Ying Luo; Yuan-Peng Xia; Bo Hu
Journal:  Biochem Biophys Res Commun       Date:  2017-02-12       Impact factor: 3.575

5.  The Evf2 Ultraconserved Enhancer lncRNA Functionally and Spatially Organizes Megabase Distant Genes in the Developing Forebrain.

Authors:  Ivelisse Cajigas; Abhijit Chakraborty; Kelsey R Swyter; Hao Luo; Monique Bastidas; Maximilliano Nigro; Elizabeth R Morris; Sean Chen; Michael J W VanGompel; David Leib; Sara J Kohtz; Marco Martina; Sooky Koh; Ferhat Ay; Jhumku D Kohtz
Journal:  Mol Cell       Date:  2018-08-23       Impact factor: 17.970

6.  Live cell imaging and proteomic profiling of endogenous NEAT1 lncRNA by CRISPR/Cas9-mediated knock-in.

Authors:  Bohong Chen; Shengcheng Deng; Tianyu Ge; Miaoman Ye; Jianping Yu; Song Lin; Wenbin Ma; Zhou Songyang
Journal:  Protein Cell       Date:  2020-05-26       Impact factor: 14.870

7.  Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.

Authors:  Kimberley J Billingsley; Maurizio Manca; Olympia Gianfrancesco; David A Collier; Helen Sharp; Vivien J Bubb; John P Quinn
Journal:  Schizophr Res       Date:  2018-02-28       Impact factor: 4.939

8.  Regulatory Role of lncRNA NONHSAT089447 in the Dopamine Signaling Pathway in Schizophrenic Patients.

Authors:  Shengdong Chen; Xiaoli Zhu; Wei Niu; Gaofeng Yao; Lingming Kong; Mingjun He; Chunxia Chen; Zhengbin Lu; Xuelian Cui; Liyi Zhang
Journal:  Med Sci Monit       Date:  2019-06-10

9.  Aberrant Expression of Long Non-Coding RNAs in Schizophrenia Patients.

Authors:  Shengdong Chen; Xinyang Sun; Wei Niu; Lingming Kong; Mingjun He; Wanshuai Li; Aifang Zhong; Jim Lu; Liyi Zhang
Journal:  Med Sci Monit       Date:  2016-09-21

10.  ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles.

Authors:  Haiyan An; Lucy Skelt; Antonietta Notaro; J Robin Highley; Archa H Fox; Vincenzo La Bella; Vladimir L Buchman; Tatyana A Shelkovnikova
Journal:  Acta Neuropathol Commun       Date:  2019-01-14       Impact factor: 7.578

View more
  3 in total

Review 1.  A putative role for lncRNAs in epigenetic regulation of memory.

Authors:  Ashleigh B Irwin; Rudhab Bahabry; Farah D Lubin
Journal:  Neurochem Int       Date:  2021-09-14       Impact factor: 3.921

2.  HBRWRLDA: predicting potential lncRNA-disease associations based on hypergraph bi-random walk with restart.

Authors:  Guobo Xie; Yinting Zhu; Zhiyi Lin; Yuping Sun; Guosheng Gu; Jianming Li; Weiming Wang
Journal:  Mol Genet Genomics       Date:  2022-06-25       Impact factor: 2.980

3.  LncRNAs in neuropsychiatric disorders and computational insights for their prediction.

Authors:  Cinmoyee Baruah; Prangan Nath; Pankaj Barah
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.